Major S&P 500 Sectors Suffer Losses Amid Poor Trading Day

Major S&P 500 sectors are lagging with the Services sector down 2.4%. Companies like Expedia Group and Dollar General faced significant losses, while the Healthcare sector also struggled, showing a 2.1% decline. Investors should remain cautious.

Date: 11-03-2025

AI Rating: 4

Sector Performance Analysis
As mentioned in the report, the Services sector is experiencing underperformance with a notable loss of 2.4%. Specifically, Expedia Group Inc (EXPE) and Dollar General Corp (DG) are lagging behind, with losses of 8.6% and 6.0%, respectively. Notably, while Expedia is down 13.17% year-to-date, Dollar General has a positive year-to-date performance at 3.40%. This inconsistent performance raises questions about the sustainability of these companies amid broader sector declines. The iShares U.S. Consumer Services ETF (IYC), tracking services stocks, is also reflecting this negativity with a 1.4% decline, contributing to a substantial year-to-date drop of 9.25%.

On the other side, the Healthcare sector is also faring poorly with a 2.1% loss. Moderna Inc (MRNA) and Bio-Techne Corp (TECH) are highlighted as notable laggards, suffering losses of 7.4% and 6.4% respectively. Year-to-date, Moderna is down 19.89%, while Bio-Techne has a significant loss of 18.14%. The Health Care Select Sector SPDR ETF (XLV) reflects that downward trend with a midday decline of 1.2%, despite a positive year-to-date increase of 6.00%.

This data suggests a challenging period for both the Services and Healthcare sectors, which could influence investor sentiment negatively. Investors should closely monitor these trends, particularly as most sectors are trending downwards, suggesting a broader market weakness.

The analysis does not provide direct insights into Earnings Per Share (EPS), Revenue Growth, Net Income, Profit Margins (Gross, Operating, Net), Free Cash Flow (FCF), or Return on Equity (ROE) for the mentioned companies, hence these aspects cannot be evaluated based on the available information.

Stocks: EXPE DG MRNA TECH